Pediatric Clinic of AOU Novara Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2017
NCT03911843
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Pediatric Clinic of AOU Novara

Active Ingredients

Drugs in Phase 3 Trials (2)

omega-3 fatty acids (Omacor) (1 trial)

vitamin d3 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus, Type 1 (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 2